Literature DB >> 33025500

Atypical clinical presentation of COVID-19 infection in residents of a long-term care facility.

Hubert Blain1, Yves Rolland2, Athanase Benetos3, Nadia Giacosa4, Mylène Albrand4, Stéphanie Miot4, Jean Bousquet5.   

Abstract

PURPOSE: To assess the magnitude of the infection in residents from-and staff working in-a long-term-care facility (LTCF) 7 days after the identification of one resident with confirmed COVID-19 infection and to assess the clinical presentation of the infected residents.
METHODS: All residents and staff members of a LTCF were tested for SARS-CoV-2 by real-time reverse-transcriptase polymerase chain reaction on nasopharyngeal swab. Residents were studied clinically 4 weeks after the first COVID diagnosis.
RESULTS: Thirty-eight of the 79 residents (48.1%) tested positive for SARS-CoV-2. Respiratory symptoms were preceded by diarrhea (26.3%), a fall (18.4%), fluctuating temperature with hypothermia (34.2%) and delirium in one resident. Respiratory symptoms, including cough and oxygen desaturation, appeared after those initial symptoms or as the first sign in 36.8% and 52.2%, respectively. At any time of the disease, fever was observed in 65.8%. Twelve deaths occurred among the COVID-19 residents. Among the 41 residents negative for SARS-CoV-2, symptoms included cough (21.9%), diarrhea (7.3%), fever (21.9%), hypothermia (9.7%), and transient hypoxemia (9.8%). No deaths were observed in this group. 27.5% of the workers were also COVID-19 positive.
CONCLUSION: The rapid dissemination of the COVID-19 infection may be explained by the delay in the diagnosis of the first cases due to atypical presentation. Early recognition of symptoms compatible with COVID-19 may help to diagnose COVID-19 residents earlier and test for SARS-CoV-2 symptomatic and asymptomatic staff and residents earlier to implement appropriate infection control practices.

Entities:  

Keywords:  COVID-19; Long-term-care facility; Testing for SARS-CoV-2; rRT-PCR

Mesh:

Year:  2020        PMID: 33025500      PMCID: PMC7538265          DOI: 10.1007/s41999-020-00352-9

Source DB:  PubMed          Journal:  Eur Geriatr Med        ISSN: 1878-7649            Impact factor:   1.710


Introduction

Older adults and those with underlying chronic medical disorders tend to be more susceptible to severe SARS-CoV-2 (COVID-19) [1, 2]. The population residing in long-term-care facilities (LTCFs) generally includes those who are both old and suffering from multiple comorbidities. A recent investigation conducted after the identification of a confirmed case of COVID-19 in a skilled nursing facility demonstrated the magnitude of the problem [3]. In this study, most of the residents with COVID-19 had respiratory illness at the moment of the diagnosis and the fatality rate was 33.7%. In another study conducted in younger residents of a skilled nursing facility, more than half of COVID-19 residents were judged asymptomatic before testing [4]. It is possible that older residents in LTCFs have specific initial atypical COVID-19 symptoms that need to be recognized rapidly. Three residents living in a LTCF were admitted for severe non-respiratory symptoms. Case 1: March 3, 2020: diarrhea with dehydration and a severe health status impairment. Case 2: March 5, 2020: fall with a wrist fracture in a woman without significant balance disturbance. Case 3: March 6, 2020: delirium, hypothermia, and hypotension in a woman with previous moderate cognitive impairment. The three residents all developed respiratory symptoms (cough with fever and dyspnea) 7–10 days after their admission to hospital and nasopharyngeal swab test confirmed COVID-19 diagnosis. All three patients died 5–7 days after diagnosis. As soon as the diagnosis was made in the first resident, infection prevention and control (ICP) measures were immediately adopted in the LTCF. The study attempted to assess the prevalence of COVID-19 infection in residents and staff members of the LTCF 7 days after the COVID-19 diagnosis of the first resident. The longitudinal symptoms of the residents were also assessed for 4 weeks.

Methods

Following local guidance, SARS-CoV-2 real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) was used on nasopharyngeal swab tests in all 79 residents and 40 health workers and on the stools of five of the residents with diarrhea. This was an observational study approved by the Montpellier University Hospital Institutional Review Board (IRB-MTP_2020_06_202000534). Symptoms in the 14 days before positive testing and until March 30 were recorded in all residents.

Results

Among the 79 residents, 38 (48.1%) were positive for SARS-CoV-2 on March 18–20, 2020. Respiratory symptoms were preceded by diarrhea in 10 (26.3%) cases, a fall in 7 (18.4%), and hypothermia in 13 (34.2%). Respiratory symptoms appeared after those symptoms or as the first sign in 24 residents (63.2%), including a dry cough in 14 (36.8%) and hypoxemia in 21 (55.2%). At any time of the disease, fever was observed in 25 residents (65.3%), most often alternating with hypothermia in 13 residents (34.2%). Three residents had no symptoms at the time of testing (7.9%), but they developed fever and cough 3–10 days later. Besides the first three deaths in the hospitalized residents, nine other COVID-19-positive residents died during the follow-up period, always less than 10 days after initial testing. This represents a total fatality rate of 31.6% (12/38) in the residents tested positive for SARS-CoV-2. The residents who died had severe hypoxemia in 12 cases (100%), hectic fever in 10 (83.3%), and diarrhea in 9 (75.0%). In all 12 cases, maximum oxygen supply was not sufficient to restore normal blood oxygen saturation. All of these residents benefited from optimal end-of-life care, three in hospital and six in the LTCF. Among the 41 residents tested negative for SARS-CoV-2, 22 (53.6%) had new symptoms in the 14 days before testing, including cough in 9 cases (21.9%), diarrhea in 3 (7.3%), fever in 2 (4.8%), hypothermia in 2 (4.8%), and dyspnea with transient hypoxemia in 4 (9.8%). No deaths were observed in this group (Table 1).
Table 1

Demographic and clinical characteristics

COVID+ residents, N = 38COVID− residents, N = 41P value**
n (%)N (%)
Age (years)*89.2 (5.6)87.3 (9.8)0.44
Gender, male8 (29.6)13 (50.0)0.13
Symptoms before respiratory symptoms
 Fluctuating temperature with hypothermia13 (34.2)2 (4.8)< 0.01
 Diarrhea10 (26.3)3 (7.3)0.06
 Fall7 (18.4)0 (0)< 0.01
Respiratory symptoms
 Cough14 (36.8)9 (21.9)0.29
 Oxygen desaturation21 (55.2)4 (9.8)< 0.01
Symptoms at any time of the 27-day follow-up
 Fever25 (65.8)9 (21.9)< 0.01
 Hypothermia13 (34.2)4 (0.7)0.03
 Diarrhea15 (39.5)10 (24.4)0.29
 Fall9 (23.7)2 (4.9)0.07
 Severe myalgia10 (26.3)1 (2.4)< 0.01
Deaths13 (31.6)0 (0)< 0.01

*Continuous variable age is expressed as mean (SD); **P for Chi-square test (or Fisher’s exact test if Chi-square was not a valid test) for categorical variables and Student test for continuous variables

Demographic and clinical characteristics *Continuous variable age is expressed as mean (SD); **P for Chi-square test (or Fisher’s exact test if Chi-square was not a valid test) for categorical variables and Student test for continuous variables In the five residents with diarrhea (two tested positive and three tested negative for SARS-CoV-2), all rectal swab tests by rRT-PCR were negative for SARS-CoV-2. On March 19, 2020, 11 of the 40 staff members (27.5%) were tested positive for SARS-CoV-2. All of them were asymptomatic or had minor complaints, such as asthenia, in the 14 days before testing. On March 30, 2020, the progression of health status of all staff members tested positive for SARS-CoV-2 was favorable.

Discussion

The present case investigation provides novel insight into COVID-19 infection in old-age adults in LTCFs and extends the papers of McMichael et al. [3] and Arons et al. [4]. There were around 50% of COVID-19 infected residents and 27.5% of health care workers. This confirms that a few days after a first case of confirmed COVID-19 in a LTCF, the number of other residents and staff members linked to the first case can be very high [3]. The rapid dissemination of COVID-19 may, at least in part, be explained by the delay in the diagnosis in the first residents and, therefore, in the implementation of appropriate infection control practices (ICPs). The first possible reason for this delay may be related to asymptomatic forms of COVID-19 at the time of testing, such as in younger people [5], those patients representing 7.3% of residents tested positive for SARS-CoV-2 of our sample vs 56% in another study conducted by Arons in a skilled nursing facility [4]. All of these cases developed typical COVID-19 symptoms after testing in the present study which is in line with previous studies conducted in younger patients [4-6]. The second possible reason of the diagnosis delay may be related to atypical symptoms preceding the respiratory symptoms and fever, including diarrhea, hypothermia, or delirium. Another interesting feature is the relatively common fall rate as the first symptom. Since COVID-19 induces severe fatigue, it can be expected that falls can be common in residents with little or no risk of fall. This symptom needs to be considered as a possible prodromal symptom of COVID-19 during the epidemic in LTCF residents. Diarrhea prevalence has been shown to increase in the later stage of the COVID-19 disease and is often associated with COVID-19 infectious stools [7]. The present study suggests that diarrhea can be a prodromal sign of COVID-19, with stools that were not infectious in five of our patients with diarrhea. The second factor that may explain, at least partly, the rapid and large COVID-19 outbreak in this LTCF is the high prevalence of staff members positive for SARS-CoV-2. The present data strongly support those of McMichel et al. [3], underlying the involuntary role of the health workers and visitors in the COVID-19 spread within this facility. They led us to take the decision to prohibit visits in the LCTF and to systematically screen for SARS-CoV-2 all staff members and residents (even asymptomatic) as soon as a case of COVID-19 was confirmed in the first resident. In addition to appropriate ICP measures, the strategies of systematic testing residents with typical and atypical COVID-19 symptoms to diagnose early the first case, and then, of early testing for SARS-CoV-2 all residents, visitors, and staff members, even asymptomatic, may be useful in controlling COVID-19 outbreaks in LTCFs, and may contribute to decreasing the case fatality ratio of the disease. In conclusion, the present study shows that the rapid dissemination of a COVID-19 infection in a LTCF may be due to a delay in the diagnosis of the first case, whose presentation could be atypical. An early recognition of atypical symptoms compatible with COVID-19 may help diagnose the first case earlier, allow early diagnosis of COVID-19 in staff, visitors, and other residents, and implement earlier targeted ICPs in the LTCF.
  7 in total

1.  Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19.

Authors:  Heather D'Adamo; Thomas Yoshikawa; Joseph G Ouslander
Journal:  J Am Geriatr Soc       Date:  2020-04-16       Impact factor: 5.562

2.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

3.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

4.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

5.  Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.

Authors:  Xi Jin; Jiang-Shan Lian; Jian-Hua Hu; Jianguo Gao; Lin Zheng; Yi-Min Zhang; Shao-Rui Hao; Hong-Yu Jia; Huan Cai; Xiao-Li Zhang; Guo-Dong Yu; Kai-Jin Xu; Xiao-Yan Wang; Jue-Qing Gu; Shan-Yan Zhang; Chan-Yuan Ye; Ci-Liang Jin; Ying-Feng Lu; Xia Yu; Xiao-Peng Yu; Jian-Rong Huang; Kang-Li Xu; Qin Ni; Cheng-Bo Yu; Biao Zhu; Yong-Tao Li; Jun Liu; Hong Zhao; Xuan Zhang; Liang Yu; Yong-Zheng Guo; Jun-Wei Su; Jing-Jing Tao; Guan-Jing Lang; Xiao-Xin Wu; Wen-Rui Wu; Ting-Ting Qv; Dai-Rong Xiang; Ping Yi; Ding Shi; Yanfei Chen; Yue Ren; Yun-Qing Qiu; Lan-Juan Li; Jifang Sheng; Yida Yang
Journal:  Gut       Date:  2020-03-24       Impact factor: 23.059

6.  A confirmed asymptomatic carrier of 2019 novel coronavirus.

Authors:  Si-Hui Luo; Wei Liu; Zhen-Jun Liu; Xue-Ying Zheng; Chang-Xing Hong; Zhi-Rong Liu; Jian Liu; Jian-Ping Weng
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

7.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
  7 in total
  16 in total

Review 1.  Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus.

Authors:  Joanna Iwanicka; Tomasz Iwanicki; Marcin Kaczmarczyk; Włodzimierz Mazur
Journal:  Pol J Microbiol       Date:  2022-06-19

2.  Health impact of the first and second wave of COVID-19 and related restrictive measures among nursing home residents: a scoping review.

Authors:  Marjolein E A Verbiest; Annerieke Stoop; Aukelien Scheffelaar; Meriam M Janssen; Leonieke C van Boekel; Katrien G Luijkx
Journal:  BMC Health Serv Res       Date:  2022-07-15       Impact factor: 2.908

3.  SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.

Authors:  Nicholas Hartog; William Faber; Austin Frisch; Jacob Bauss; Caleb P Bupp; Surender Rajasekaran; Jeremy W Prokop
Journal:  Expert Rev Proteomics       Date:  2021-04-05       Impact factor: 3.940

4.  Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020.

Authors:  Tran Duc Anh Ly; Didier Zanini; Vincent Laforge; Sylvie Arlotto; Stephanie Gentile; Helene Mendizabal; Michael Finaud; David Morel; Olivier Quenette; Priscilla Malfuson-Clot-Faybesse; Alain Midejean; Phuc Le-Dinh; Gérard Daher; Berengere Labarriere; Anne-Marie Morel-Roux; Alain Coquet; Patrick Augier; Philippe Parola; Eric Chabriere; Didier Raoult; Philippe Gautret
Journal:  Int J Antimicrob Agents       Date:  2020-11-13       Impact factor: 5.283

5.  Clinical Presentation, Course, and Risk Factors Associated with Mortality in a Severe Outbreak of COVID-19 in Rhode Island, USA, April-June 2020.

Authors:  Eleftheria Atalla; Raina Zhang; Fadi Shehadeh; Evangelia K Mylona; Maria Tsikala-Vafea; Saisanjana Kalagara; Laura Henseler; Philip A Chan; Eleftherios Mylonakis
Journal:  Pathogens       Date:  2020-12-24

6.  Analysing different exposures identifies that wearing masks and establishing COVID-19 areas reduce secondary-attack risk in aged-care facilities.

Authors:  Bastien Reyné; Christian Selinger; Mircea T Sofonea; Stéphanie Miot; Amandine Pisoni; Edouard Tuaillon; Jean Bousquet; Hubert Blain; Samuel Alizon
Journal:  Int J Epidemiol       Date:  2021-06-21       Impact factor: 9.685

7.  Analysing different exposures identifies that wearing masks and establishing COVID-19 areas reduce secondary-attack risk in aged-care facilities.

Authors:  Bastien Reyné; Christian Selinger; Mircea T Sofonea; Stéphanie Miot; Amandine Pisoni; Edouard Tuaillon; Jean Bousquet; Hubert Blain; Samuel Alizon
Journal:  Int J Epidemiol       Date:  2021-06-21       Impact factor: 7.196

8.  Should lung ultrasound be always performed in older patients with possible COVID-19 disease?

Authors:  Costantino Caroselli; Antonio Cherubini
Journal:  Eur Geriatr Med       Date:  2021-12       Impact factor: 1.710

9.  Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.

Authors:  Antonella Savio; Stefano Calza; Gianbattista Guerrini; Valentina Romano; Eleonora Marchina
Journal:  Front Public Health       Date:  2021-06-24

10.  August 2020 Interim EuGMS guidance to prepare European Long-Term Care Facilities for COVID-19.

Authors:  Hubert Blain; Yves Rolland; Jos M G A Schols; Antonio Cherubini; Stéphanie Miot; Desmond O'Neill; Finbarr C Martin; Olivier Guérin; Gaëtan Gavazzi; Jean Bousquet; Mirko Petrovic; Adam L Gordon; Athanase Benetos
Journal:  Eur Geriatr Med       Date:  2020-11-03       Impact factor: 1.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.